Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp (Nasdaq: FLAC) is a blank-check company sponsored by Frazier Life Sciences, the dedicated life sciences investment arm of Frazier Healthcare Partners, targeting acquisition opportunities in biotechnology, pharmaceuticals, medical devices, and diagnostics. FLAC completed its initial public offering in 2021 amid a period of elevated healthcare-focused SPAC issuance and subsequently pursued a qualifying business combination within those sectors. An 8-K filed with the SEC on November 15, 2022, accession number 0001193125-22-285506, reflects the company's continued disclosure obligations during its search period. Investors and analysts tracking life sciences SPAC activity can access FLAC's full filing history, sponsor profile, and current status on SpacDesk — sign up today for complete data.